Learning Hub Central

Pharmacology

2025 SPS Seattle | Impact of Pharmacists Embedded in Specialty Clinics

2025 SPS Seattle | Impact of Pharmacists Embedded in Specialty Clinics

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Seattle | Vutrisiran in the Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy

2025 SPS Seattle | Vutrisiran in the Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Seattle | Pharmacy Services in Integrative Medicine

2025 SPS Seattle | Pharmacy Services in Integrative Medicine

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting

2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Seattle | 505(b)(2) Therapeutics: Practice Considerations

2025 SPS Seattle | 505(b)(2) Therapeutics: Practice Considerations

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Seattle | It is a New Generation of GI Gen Zs: Zolbetuximab, Zanidatamab, Zenocutuzumab

2025 SPS Seattle | It is a New Generation of GI Gen Zs: Zolbetuximab, Zanidatamab, Zenocutuzumab

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Updates on Metastatic HR+ Breast Cancer

2025 SPS Minneapolis | Updates on Metastatic HR+ Breast Cancer

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Inflation Reduction Act (IRA): The Patient & Provider Perspective

2025 SPS Minneapolis | Inflation Reduction Act (IRA): The Patient & Provider Perspective

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Hodgkin Lymphoma Front Line Efficacy & Toxicity Considerations

2025 SPS Minneapolis | Hodgkin Lymphoma Front Line Efficacy & Toxicity Considerations

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Compassionate Access to Investigational Drugs

2025 SPS Minneapolis | Compassionate Access to Investigational Drugs

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Operationalization of Talimogene Laherparepvec (T-VEC) Therapy

2025 SPS Minneapolis | Operationalization of Talimogene Laherparepvec (T-VEC) Therapy

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Real-World Experience: CDK 4/6 Inhibitors Medication Management Clinic

2025 SPS Minneapolis | Real-World Experience: CDK 4/6 Inhibitors Medication Management Clinic

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors:  Clinical Implications & Challenges of Antibody Drug Conjugates

2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Operationalization of Tumor-Infiltrating Lymphocyte (TIL) Therapy

2025 SPS Minneapolis | Operationalization of Tumor-Infiltrating Lymphocyte (TIL) Therapy

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Imetelstat’s Role in the Management of Myelodysplastic Syndrome (MDS)

2025 SPS Minneapolis | Imetelstat’s Role in the Management of Myelodysplastic Syndrome (MDS)

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Implementation of a Pharmacogenomics Service in Pediatric Setting

2025 SPS Minneapolis | Implementation of a Pharmacogenomics Service in Pediatric Setting

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Oral Oncolytics Collaborative Practice Agreements (CPA) Elevating Pharmacy Practice in Cancer Care

2025 SPS Minneapolis | Oral Oncolytics Collaborative Practice Agreements (CPA) Elevating Pharmacy Practice in Cancer Care

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Mantle Cell Lymphoma Emerging Combination & Place in Therapy

2025 SPS Minneapolis | Mantle Cell Lymphoma Emerging Combination & Place in Therapy

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Minneapolis | Drug Formulary Management & Optimization Strategies

2025 SPS Minneapolis | Drug Formulary Management & Optimization Strategies

Pharmacology

1 Chapter

Non-CME Credit Course

2025 CCC | Role of Pharmacokinetics in Early Phase Clinical Trials

2025 CCC | Role of Pharmacokinetics in Early Phase Clinical Trials

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Puerto Rico | Tarlatamab, Bringing Bispecific Treatment Options to Thoracic Oncology

2025 SPS Puerto Rico | Tarlatamab, Bringing Bispecific Treatment Options to Thoracic Oncology

Pharmacology

1 Chapter

Non-CME Credit Course

2025 SPS Puerto Rico | A View into Puerto Rico’s Patient Demographics and Healthcare Research

2025 SPS Puerto Rico | A View into Puerto Rico’s Patient Demographics and Healthcare Research

Pharmacology

1 Chapter

Non-CME Credit Course

Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey

Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey

Pharmacology

1 Chapter

Non-CME Credit Course

Launching a Busulfan Kinetics Pharmacy Service; Real-World Case in Community Hospital Setting

Launching a Busulfan Kinetics Pharmacy Service; Real-World Case in Community Hospital Setting

Pharmacology

1 Chapter

Non-CME Credit Course

Oncology Pharmacy Operations Efficiency Journey

Oncology Pharmacy Operations Efficiency Journey

Pharmacology

1 Chapter

Non-CME Credit Course

Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics

Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics

Pharmacology

1 Chapter

Non-CME Credit Course

Pharmacotherapy Updates in Malignant Hematology; Bispecifics and CAR-T Cell Therapies

Pharmacotherapy Updates in Malignant Hematology; Bispecifics and CAR-T Cell Therapies

Pharmacology

1 Chapter

Non-CME Credit Course

Attracting, Recruiting and Retaining the Oncology Pharmacy Talent

Attracting, Recruiting and Retaining the Oncology Pharmacy Talent

Pharmacology

1 Chapter

Non-CME Credit Course

Minimizing Waste by Maximizing BUDs: Immediate Use Compounding for Biologics

Minimizing Waste by Maximizing BUDs: Immediate Use Compounding for Biologics

Pharmacology

1 Chapter

Non-CME Credit Course

The Art and the Science of Formulary Management | Acute to Ambulatory Strategies

The Art and the Science of Formulary Management | Acute to Ambulatory Strategies

Pharmacology

1 Chapter

Non-CME Credit Course

Drug Brown and White Bagging: What is It and Where Does it Lead Us?

Drug Brown and White Bagging: What is It and Where Does it Lead Us?

Pharmacology

1 Chapter

Non-CME Credit Course

2022 CCC | Bayesian Designs in Clinical Trials

2022 CCC | Bayesian Designs in Clinical Trials

Pharmacology

1 Chapter

Non-CME Credit Course

2022 CCC | PK and PD Considerations in Early Phase Clinical Trials

2022 CCC | PK and PD Considerations in Early Phase Clinical Trials

Pharmacology

1 Chapter

Non-CME Credit Course

White-Bagging Journey in Florida; Strategies to Protect Practice and Patients

White-Bagging Journey in Florida; Strategies to Protect Practice and Patients

Pharmacology

1 Chapter

Non-CME Credit Course

MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo